MSLN and cancer: Mesothelin (MSLN) is a cell-surface glycoprotein with limited expression on normal tissue but is overexpressed in many solid cancers, including ovarian, lung, and pancreatic carcinomas, making MSLN a promising target for cancer therapies, including CAR-engineered cell therapies41,42.